Correspondence 0001213900-23-098808 from Investment Managers Series Trust II (CIK 0001587982)
Investment Managers Series Trust II (CIK 0001587982)
Date: Dec. 27, 2023 · CIK: 0001587982 · Accession: 0001213900-23-098808
AI Filing Summary & Sentiment
File numbers found in text: 333-191476, 811-22894
Letter
INVESTMENT MANAGERS SERIES TRUST II
W. Galena Street
Milwaukee, Wisconsin 53212
VIA EDGAR
December 27, 2023
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention: Division of Investment Management
Re: Investment Managers Series Trust II (the “Registrant”) (File Nos. 333-191476 and 811-22894)
on behalf of the First Trust Multi-Strategy Fund (the “Fund”)
Ladies and Gentlemen:
This letter summarizes the comments provided to me by Ms. Samantha Brutlag of the staff of the Securities and Exchange Commission (the “Commission”) by telephone on December 22, 2023, with respect to the Registrant’s Preliminary Proxy Statement filed on December 14, 2023. Responses to all of the comments are included below and, as appropriate, will be reflected in the Definitive Proxy Statement that will be filed separately. Capitalized terms not otherwise defined in this letter have the meanings assigned to them in the Proxy Statement.
The Registrant notes that the name of CBOE VestSM Financial LLC, the proposed new sub-advisor to the Fund, will change to Vest Financial LLC effective January 2, 2024. The Registrant has added a footnote to the Definitive Proxy Statement noting this upcoming change.
1. Please confirm the Definitive Proxy Statement filing will contain all required information pursuant to Item 22(c) of Schedule 14A.
Response: The Registrant confirms that the Definitive Proxy Statement filing will contain all required information pursuant to Item 22(c) of Schedule 14A.
2. Under “Approval of CBOE Vest as Sub-Advisor to the Fund” on page 8 of the Proxy Statement, the second sentence of the first paragraph reads “[u]pon approval by shareholders, the New Sub-Advisory Agreement will become effective and the current investment sub-advisory agreement with Glenmede will terminate after Glenmede’s sleeve is wound down.” Please revise this sentence to be in plain English.
Response: The Registrant has revised the second sentence of the first paragraph as follows:
Upon approval by shareholders, the New Sub-Advisory Agreement will become effective, and the portion of the Fund’s portfolio managed by Glenmede will be reallocated to CBOE Vest. After completion of the reallocation, the current investment sub-advisory agreement with Glenmede will terminate after Glenmede’s sleeve is wound down.
* * * * *
The Registrant believes that it has fully responded to each comment. If, however, you have any further questions or required further clarification of any response, please contact me at (626) 385-5777.
Sincerely,
/s/
DIANE J. DRAKE
Show Raw Text
CORRESP
1
filename1.htm
INVESTMENT
MANAGERS SERIES TRUST II
235
W. Galena Street
Milwaukee,
Wisconsin 53212
VIA EDGAR
December 27, 2023
U.S. Securities and Exchange
Commission
100 F Street, NE
Washington, DC 20549
Attention: Division of
Investment Management
Re: Investment
Managers Series Trust II (the “Registrant”) (File
Nos. 333-191476 and 811-22894)
on behalf of the First Trust Multi-Strategy Fund (the
“Fund”)
Ladies
and Gentlemen:
This
letter summarizes the comments provided to me by Ms. Samantha Brutlag of the staff of the Securities and Exchange Commission (the “Commission”)
by telephone on December 22, 2023, with respect to the Registrant’s Preliminary Proxy Statement filed on December 14, 2023. Responses
to all of the comments are included below and, as appropriate, will be reflected in the Definitive Proxy Statement that will be filed
separately. Capitalized terms not otherwise defined in this letter have the meanings assigned to them in the Proxy Statement.
The
Registrant notes that the name of CBOE VestSM Financial LLC, the proposed new sub-advisor to the Fund, will change to Vest
Financial LLC effective January 2, 2024. The Registrant has added a footnote to the Definitive Proxy Statement noting this upcoming change.
1. Please
confirm the Definitive Proxy Statement filing will contain all required information pursuant
to Item 22(c) of Schedule 14A.
Response:
The Registrant confirms that the Definitive Proxy Statement filing will contain all required information pursuant to Item 22(c) of Schedule
14A.
2. Under
“Approval of CBOE Vest as Sub-Advisor to the Fund” on page 8 of the Proxy Statement,
the second sentence of the first paragraph reads “[u]pon approval by shareholders,
the New Sub-Advisory Agreement will become effective and the current investment sub-advisory
agreement with Glenmede will terminate after Glenmede’s sleeve is wound down.”
Please revise this sentence to be in plain English.
Response:
The Registrant has revised the second sentence of the first paragraph as follows:
Upon
approval by shareholders, the New Sub-Advisory Agreement will become effective, and the portion of the Fund’s portfolio
managed by Glenmede will be reallocated to CBOE Vest. After completion of the reallocation, the current investment sub-advisory agreement
with Glenmede will terminate after Glenmede’s sleeve is wound down.
* *
* * *
The
Registrant believes that it has fully responded to each comment. If, however, you have any further questions or required further clarification
of any response, please contact me at (626) 385-5777.
Sincerely,
/s/
DIANE J. DRAKE
Diane
J. Drake
Secretary